Fate Therapeutics Q3 Results Expected October 29
Fate Therapeutics is scheduled to report Q3'26 results on October 29; the time is unspecified. Revenue is estimated at 1.14 million USD and EPS at (0.27) USD.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Fate Therapeutics Q3 Results Expected October 29
Fate Therapeutics is scheduled to report Q3'26 results on October 29. EPS is anticipated at $(0.27); the release time is not specified.